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Introduction
Comorbidity may be defined as the presence of any addi-
tional coexistent condition in a patient with an index dis-
ease or as an association between two disorders that is
more than coincidental [1]. The presence of a comorbidi-
ty may complicate diagnosis because of overlapping
symptoms. As stated by Lipton and Silberstein [2], comor-
bidity may arise by coincidence or selection bias, one con-
dition may cause the other, both conditions may be relat-
ed to shared environmental genetic risk factors, and the
same environmental or genetic risk factors may determine
a brain state that gives rise to both conditions.
Comorbid neuropathologies in migraine, as shown in
Table 1, may involve mood disorders (depression, mania,
anxiety, panic attacks), epilepsy, essential tremor, stroke
and white matter abnormalities [1].
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Abstract The identification of
comorbid disorders in migraineurs
is important since it may impose
therapeutic challenges and limit
treatment options. Moreover, the
study of comorbidity might lead to
improve our knowledge about
causes and consequences of
migraine. Comorbid neuropatholo-
gies in migraine may involve
mood disorders (depression,
mania, anxiety, panic attacks),
epilepsy, essential tremor, stroke,
and white matter abnormalities.
Particularly, a complex bidirection-
al relation exists between migraine
and stroke, including migraine as a
risk factor for cerebral ischemia,
migraine caused by cerebral
ischemia, migraine as a cause of
stroke, migraine mimicking cere-
bral ischemia, migraine and cere-
bral ischemia sharing a common
cause, and migraine associated
with subclinical vascular brain
lesions. 
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Migraine and psychiatric disorders
The prevalence of behavioural disorders such as major
depression, mania or hypomania, generalised anxiety and
social phobia is higher in subjects with migraine than in
those without migraine [3]. Epidemiologic studies report an
association between migraine headache and major depres-
sion [3–6]. The association might be noncausal, reflecting
shared genetic or environmental pathogenic determinants.
Alternatively, migraine might cause major depression or
might be caused by it. The hypothesis that depression in
persons with migraine may reflect a psychological response
to the stress of recurrent severe headaches would predict an
influence only from migraine to depression but not from
depression to migraine. In contrast, the hypothesis of
shared causes would predict that each disorder might
increase the risk of first-time occurrence of the other. Some
studies suggested bidirectional influences between
migraine and major depression, with each disorder increas-
ing the risk of first onset of the other [6, 7]. Moreover, the
fact that prevention of migraine attacks might benefit from
treatments with some antidepressant agents (Table 2) sup-
ports the presence of shared mechanisms.
Besides, the association between migraine and depres-
sion is better proven for migraine with aura than for
migraine without aura [8].
Migraine and epilepsy
Migraine and epilepsy are both chronic neurologic dis-
orders with episodic attacks. Both migraine and epilep-
sy represent distinct families of neurological disorders
with typical constellations of symptoms. Migraine is
characterised by recurrent attacks of pain and associat-
ed symptoms. Epilepsy is characterised by recurrent
attacks of positive neurological symptoms, often pro-
gressing to altered or lost consciousness and, at times,
by convulsive features. The sensory, motor and cogni-
tive characteristics of migraine and epilepsy often over-
lap. Auras, hallucinations, changes in mood and behav-
iour or consciousness, and focal sensory or motor symp-
toms may occur in both conditions. Both disorders may
present with headache. Furthermore, as migraine and
epilepsy are highly comorbid, many individuals have
both disorders, further complicating accurate diagnosis.
Many patients complain of headaches after seizures and
in some cases the migraine aura can trigger seizures, as
anticipated by Andermann and Andermann [9], who
coined the term migralepsy specifically referring to this
condition. However, in many patients, migraine and
epileptic attacks are not temporally related. According
to Lipton et al. [10], the risk of migraine is more than
twice as high in persons with epilepsy, whether
probands or relatives, than in persons without epilepsy.
Besides, the risk of migraine is increased in persons
with epilepsy caused by head trauma and is present in
every subgroup of epileptic patients, defined by seizure
type, age at onset, aetiology or family history. The
prevalence of epilepsy in patients with migraine ranges
from 1% to 17%, with a median of 5.9%. This percent-
age greatly exceeds that found in the general population,
which is approximately 0.5% [11]. In contrast, the
prevalence of migraine in patients with epilepsy ranges
from 8% to 15% [12]. Additionally, the therapeutic
options for the two disorders overlap, as antiepileptic
drugs such are currently used also for migraine preven-
tion (Table 3).
Migraine and tremor
As reported by Biary et al. [13], unexplainably, essential
tremor and migraine occur together more frequently than
just by chance alone. Accordingly, the prevalence of
migraine in patients with essential tremor is 36% com-























pared with a prevalence of 18% in normal controls.
Similarly, essential tremor occurs in about 17% of patients
with migraine, compared with only 1% of controls.
Migraine and stroke
A complex bidirectional relationship exists between
migraine and stroke (Table 4), including migraine as a risk
factor for cerebral ischaemia, migraine caused by cerebral
ischaemia, migraine as a cause of stroke, migraine mimic-
king cerebral ischaemia, migraine and cerebral ischaemia
sharing a common cause, and migraine associated with
subclinical vascular brain lesions [14–16].
Migraine as a risk factor for cerebral ischaemia
The fact that migraine might be considered as a risk fac-
tor for cerebral ischaemia has long been debated [17].
To speak of this possibility, a clearly clinically defined
stroke syndrome must occur remotely in time from a
typical attack of migraine [18]. History of migraine may
contribute to the risk of stroke through an unspecified
mechanism. Several case-control studies investigated
the relationship between migraine and stroke: the odds
ratio was 4.3 (1.2–16.3; 95% CI) in women under 45
years of age according to Tzourio et al. [19] and 3.7
(1.5–9.0; 95% CI) according to Carolei et al. [20].
Besides, odds ratios were higher in patients with a his-
tory of migraine with aura than in patients with a histo-
ry of migraine without aura. According to Carolei et al.
[20], the rare association between migraine and cerebral
ischaemia was limited to women below the age of 35
years and suggests careful clinical evaluation of comor-
bidity in the presence of migraine with aura [20]. The
added risk of stroke (odds ratios) to a female migraineur
under the age of 45 doubles from 3 (in the presence of
migraine without aura) to 6 (in the presence of migraine
with aura), to 13.9 (in the presence of migraine and oral
contraceptives use). A more recent study confirmed the
increased risk of total and ischaemic stroke for
migraineurs with aura with respect to migraineurs with-
out aura indicating a low absolute risk increase, with 3.8
additional cases per year per 10,000 women [21]. This
fact might be due to a higher cardiovascular risk profile
of migraineurs with respect to controls and particularly
of migraineurs with aura. The GEM population-based
study reported that, compared to controls, migraineurs
were more likely to smoke, less likely to drink alcohol
and more likely to report a parental history of early
myocardial infarction. Migraineurs with aura were more
likely to have an unfavourable cholesterol profile, to
have elevated blood pressure and to report a history of
early onset coronary heart disease or stroke; female
migraineurs with aura were more likely to be using oral
contraceptives [22].
Migraine caused by cerebral ischaemia
Migraine caused by cerebral ischaemia is also referred to
as symptomatic migraine. It is diagnosed when an estab-
lished structural central nervous system lesion produces
typical episodes of migraine with or without neurologic
aura. This is the case of migraine-like headaches that are
attributed to ischaemic stroke or transient ischaemic
attack but also the case of migraine-like headaches attrib-
uted to nontraumatic intracranial haemorrhage, which are
extensively described in Chapter 6 of The International
Classification of Headache Disorders, second edition
(ICHD-II) (Table 5) [23].
The close temporal relation between the stroke and the
onset of the headache is the main factor supporting the
diagnosis as well as the resolution of the headache after
the acute phase, although in some cases headache may
become chronic. A migraine-like headache is often the
presenting clinical feature in patients with arterial dissec-
tion and it is reported in the ICHD as headache or facial
or neck pain attributed to arterial dissection (ICHD-II,
6.5.1) (Table 6) [23].
It usually precedes the onset of retinal or brain
ischaemia by hours or days. The presence of a new onset
migraine headache in association with an ipsilateral
Horner’s syndrome is highly suggestive of carotid dissec-
tion and requires mandatory and urgent neurovascular
investigations (Fig. 1) [24].
Migraine as a cause of stroke
Migraine as a cause of stroke was first recognised by
Charcot. As suggested by Welch [18], to diagnose
Table 4 Relationship between migraine and stroke
Migraine as a risk factor for cerebral ischaemia
Migraine caused by cerebral ischaemia
Migraine as a cause of stroke
Migraine mimicking cerebral ischaemia
Migraine and cerebral ischaemia sharing a common cause
Migraine associated with subclinical vascular brain lesions
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migraine-induced stroke the neurological deficit must
exactly mimic the migrainous symptoms of previous
attacks; the stroke must occur during the course of a typi-
cal migraine attack; all other causes of stroke must be
excluded although stroke risk factors may be present.
Besides migraine as a cause of cerebral infarction is
extremely rare, is vastly over diagnosed and should be
diagnosed only by exclusion. Migraine-induced stroke
represents the same clinical entity considered in the
ICHD-II as migrainous infarction (ICHD-II, 1.5.4) [23],
occurring when one or more symptoms and signs of
migrainous aura persist for more than 60 min and are
associated with neuroimaging confirmation of ischaemic
infarction in a relevant area (Table 7 and Fig. 2).
Migrainous infarcts are considered a direct conse-
quence of an unusually severe hypoperfusion during aura.
There is no consistent pattern of infarction, as infarcts
Table 5 Diagnostic criteria of migraine-like headaches induced by stroke according to ICHD-II (Chapter 6)
6.1 Headache attributed to ischaemic stroke or transient ischaemic attack
6.1.1 Headache attributed to ischaemic stroke (cerebral infarction)
Diagnostic criteria:
A. Any new acute headache fulfilling criterion C
B. Neurological signs and/or neuroimaging evidence of a recent ischaemic stroke
C. Headache develops simultaneously with or in close temporal relation to signs or other evidence of ischaemic stroke
6.1.2 Headache attributed to transient ischaemic attack
Diagnostic criteria:
A. Any new acute headache fulfilling criteria C and D
B. Focal neurological deficit of ischaemic origin lasting <24 h
C. Headache develops simultaneously with onset of focal deficits
D. Headache resolves within 24 h
6.2 Headache attributed to nontraumatic intracranial haemorrhage
6.2.1 Headache attributed to intracerebral haemorrhage
Diagnostic criteria:
A. Any new acute headache fulfilling criterion C
B. Neurological signs or neuroimaging evidence of recent nontraumatic intracerebral haemorrhage
C. Headache develops simultaneously with or in close temporal relation to intracerebral haemorrhage
6.2.2 Headache attributed to subarachnoid haemorrhage
Diagnostic criteria
A. Severe headache of sudden onset fulfilling criteria C and D
B. Neuroimaging (CT or MRI T2 or FLAIR) or cerebrospinal fluid evidence of nontraumatic subarachnoid haemorrhage 
with or without other neurological signs
C. Headache develops simultaneously with haemorrhage
D. Headache resolves within 1 month
Table 6 Diagnostic criteria of migraine-like headache attributed to arterial dissection according to ICHD-II (Chapter 6)
6.5 Carotid or vertebral artery pain
6.5.1 Headache or facial or neck pain attributed to arterial dissection
Diagnostic criteria:
A. Any new headache, facial pain or neck pain of acute onset, with or without other neurological symptoms or signs 
and fulfilling criteria C and D
B. Dissection demonstrated by appropriate vascular and/or neuroimaging investigations
C. Pain develops in a close temporal relation to and on the same side as the dissection
D. Pain resolves within 1 month
Fig. 1 Digital angiography showing a dissection of the left internal
carotid artery in a patient presenting with a new onset migraine-
like headache associated with ipsilateral Horner’s syndrome
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may be large, small, single, multiple, cortical, subcortical
and involve both carotid and vertebral-basilar territories.
However, the most common pattern is an infarction
involving the posterior cerebral artery presenting as a
visual field defect.
Migraine mimicking cerebral ischaemia
Migraine mimicking cerebral ischaemia refers to cases
of stroke caused by acute and progressive structural dis-
ease accompanied by headache and focal neurologic
symptoms that are difficult to distinguish from migraine
with aura. A differential diagnosis is particularly trou-
blesome in patients who continue to have migraine with
aura late in life when the incidence of cerebrovascular
disease increases. The differential diagnosis between a
migraine aura and a transient ischaemic attack may be
particularly challenging in some cases. The helpful crite-
ria to differentiate the two conditions are summarised in
Table 8.
Migraine and cerebral ischaemia sharing a common cause
Migraine and cerebral ischaemia sharing a common
cause include syndromes in which both migraine and
stroke are major clinical features. These conditions are
characterised by chronic alterations of the vessel wall of
small arteries and include cerebral autosomal dominant
arteriopathy with subcortical infarcts and leucoen-
cephalopathy (CADASIL), mitochondrial encephalopa-
thy, lactic acidosis and stroke-like episodes (MELAS),
and autosomal dominant vascular retinopathy, migraine
and Raynaud’s phenomenon. The first two conditions are
also described in Chapter 6 of ICHD-II (6.7.1 and 6.7.2)
(Table 9) [23].
CADASIL is an autosomal dominant disease, affecting
smooth muscle cells of cerebral arteries, caused by a
mutation in the gene Notch 3. It is characterised by recur-
rent strokes or transient ischaemic attacks, subcortical
vascular dementia and migraine with aura. Migraine with
aura is the most common clinical feature of the disease,
present in one third of cases and is also the first clinical
manifestation. It appears around the age of 30 years and
precedes stroke by about 15–20 years and death by about
20–30 years. In CADASIL aura attacks tend to be partic-
ularly prolonged and frequent and they are not always fol-
lowed by a typical migraine headache. Brain magnetic
resonance imaging (Fig. 3) is always abnormal in
CADASIL patients, showing ischaemic areas and white
matter changes on T2-weighted images; the diagnosis may
be further confirmed by a skin biopsy with immunostain-
ing of Notch 3 antibodies [25–27].
MELAS is an inherited disease caused by a point
mutation in the mitochondrial DNA. It is characterised
by migraine with or without aura, stroke episodes and
Table 7 Diagnostic criteria of migrainous infarction according to ICHD-II (Chapter 1)
1.5 Complications of migraine
1.5.4 Migrainous infarction
Diagnostic criteria:
A. The present attack in a patient with 1.2. Migraine with aura is typical of previous attacks except that one or more aura 
symptoms persists for >60 min
B. Neuroimaging demonstrates ischaemic infarction in a relevant area
C. Not attributed to another disorder
Fig. 2 Brain magnetic resonance imaging (diffusion-weighted
images) showing a migraine-induced stroke in the left occipital lobe
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seizures [28, 29]. Another condition in which both
migraine and stroke might share a common cause is
patent foramen ovale (PFO) [30–32]. PFO has been
associated with cryptogenic stroke episodes caused by
paradoxical embolism through the PFO. The incidence
of migraine with aura is about 50% in cryptogenic
stroke patients who have a PFO, instead of the 12%
found in the general population. Moreover, the closure
of the PFO has been associated with suppression of
migraine attacks [33, 34].
Migraine associated with subclinical vascular brain
lesions
Migraine has also been associated with subclinical vascu-
lar brain lesions (Fig. 4) [35]. A Dutch study [36], howev-
er, did not show any significant difference in infarct preva-
lence between migraineurs and nonmigraineurs, although
cerebellar lesions were more common in patients with
migraine, particularly in those with aura and with frequent
attacks, than in people who did not have migraine. Among
Table 8 Criteria to differentiate a migraine aura from a transient ischaemic attack
Migraine with aura Transient ischaemic attack
Slow evolution of visual and sensory symptoms Sudden onset
Serial progression of symptoms Quick progression
Two or more identical attacks No identical attacks
Complete recovery from attacks Usually precede stroke
Duration longer than 20 min Brief duration (1–30 min)
Followed by migraine headache Rarely followed by nonmigraine headache
Most common in the young Most common in middle-aged and elderly persons
Table 9 Diagnostic criteria of headache attributed to other intracranial vascular disorders according to ICHD-II (Chapter 6)
6.7 Headache attributed to other intracranial vascular disorders
6.7.1 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Diagnostic criteria:
A. Attacks of migraine with aura with or without neurological signs
B. Typical white matter changes on T2 weighted images
C. Diagnostic confirmation from skin biopsy evidence or genetic testing (Notch 3 mutations)
6.7.2 Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS)
Diagnostic criteria:
A. Attacks of migraine with or without aura
B. Stroke-like episodes and seizures
C. Genetic abnormality (3243 point mitochondrial DNA mutation in the tRNA Leu gene or other DNA MELAS point mutation)
Fig. 3 Brain magnetic resonance
imaging (T1-weighted images on
the left and T2 FLAIR images on
the right) in a patient diagnosed
with CADASIL
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women, but not men, deep white matter lesions were more
prevalent in those with migraine irrespective of type and
increased with the frequency of the attacks. Oral contra-
ceptive use further increased the risk of deep lesions, while
triptans use did not confer an increased risk of subclinical
lesions. The results of the Dutch study support the hypoth-
esis that the brain parenchyma supplied by the posterior
circulation is a well known and particularly common site
of migraine-related stroke.
Migraine and white matter abnormalities
Since the advent of magnetic resonance imaging, white
matter abnormalities (Fig. 5) have been described in sub-
jects with migraine, although there has been some debate
over whether the prevalence exceeds that found in patients
without migraine.
The cause of these lesions has still not been clarified.
However their presence in migraineurs has been associated
with increased age and increased prevalence of cerebrovas-
cular risk factors [16]. A meta-analysis summarised the
results from seven case-control studies that considered the
possible association between migraine and white matter
abnormalities [37]. The pooled risk of white matter abnor-
malities associated with migraine from those studies was
approximately four-fold (OR 3.9; 95% CI 2.3–6.7), with the
odds ratios similar for studies that included (OR 3.6; 95%
CI 1.5–8.4) or excluded (OR 4.1; 95% CI 2.1–8.4) individ-
uals with risk factors for cerebrovascular disease [37].
Conclusions
The identification of comorbid disorders in migraineurs is
important as it may impose therapeutic challenges and
limit treatment options. Moreover, the study of comorbid-
ity might lead to improve our knowledge about causes and
consequences of migraine.
Fig. 4 Brain magnetic resonance imaging (T2-weighted images) show-
ing subcortical asymptomatic brain lesions in a migrainous patient
Fig. 5 Brain magnetic resonance
imaging (T2-weighted images on
the left and FLAIR images on the
right) showing subcortical white
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